Serum potassium and heart failure: association, causation, and clinical implications
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum potassium and heart failure: association, causation, and clinical implications
Authors
Keywords
-
Journal
HEART FAILURE REVIEWS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-24
DOI
10.1007/s10741-020-10039-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association between potassium level and outcomes in heart failure with reduced ejection fraction: a cohort study from the Swedish Heart Failure Registry
- (2020) Lauren B. Cooper et al. EUROPEAN JOURNAL OF HEART FAILURE
- Abnormalities of Potassium in Heart Failure
- (2020) João Pedro Ferreira et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis
- (2019) Ricky D. Turgeon et al. PLoS One
- Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments
- (2019) Faiez Zannad et al. EUROPEAN HEART JOURNAL SUPPLEMENTS
- Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate
- (2019) Giuseppe M C Rosano et al. EUROPEAN HEART JOURNAL SUPPLEMENTS
- Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology
- (2019) Petar M. Seferovic et al. EUROPEAN JOURNAL OF HEART FAILURE
- Associations between serum potassium and adverse clinical outcomes: a systematic literature review
- (2019) Eirini Palaka et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Serum Potassium and Cardiovascular Events in Heart Failure With Preserved Left Ventricular Ejection Fraction Patients
- (2018) Taiki Nishihara et al. AMERICAN JOURNAL OF HYPERTENSION
- Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF
- (2018) Joost C. Beusekamp et al. EUROPEAN JOURNAL OF HEART FAILURE
- Hypokalemia-Induced Arrhythmias and Heart Failure: New Insights and Implications for Therapy
- (2018) Jonas Skogestad et al. Frontiers in Physiology
- Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction
- (2018) Gianluigi Savarese et al. JACC-Heart Failure
- Associations of serum potassium levels with mortality in chronic heart failure patients
- (2017) Mette Aldahl et al. EUROPEAN HEART JOURNAL
- Serum Potassium Levels and Outcome in Patients With Chronic Heart Failure
- (2016) Sarah Hoss et al. AMERICAN JOURNAL OF CARDIOLOGY
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- An Integrated View of Potassium Homeostasis
- (2015) Michelle L. Gumz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence, Predictors, and Outcomes Related to Hypo- and Hyperkalemia in Patients With Severe Heart Failure Treated With a Mineralocorticoid Receptor Antagonist
- (2014) Orly Vardeny et al. Circulation-Heart Failure
- Incident hyperkalemia may be an independent therapeutic target in low ejection fraction heart failure patients: Insights from the HEAAL study
- (2014) P. Rossignol et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy
- (2013) Patrick Rossignol et al. Circulation-Heart Failure
- Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry
- (2013) Aldo P. Maggioni et al. EUROPEAN JOURNAL OF HEART FAILURE
- Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study
- (2012) Michael Böhm et al. Clinical Research in Cardiology
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Theo Vos et al. LANCET
- The meaning of hypokalemia in heart failure
- (2011) Agata Bielecka-Dabrowa et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
- (2010) Karl Swedberg et al. LANCET
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
- (2009) Marvin A Konstam et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started